You searched for: cancer
1 to 10 of 17 results
Show
results per page
Matched phrases in profile:
MPS and cancer prognosis, circulating fDNA, Sentinel Node biopsy trials Breast Cancer Audit and cancer registries… Is parathyroid hormone-related protein a sensitive serum marker in advanced breast cancer?… Whole Genome Sequencing in high-risk breast cancer patients.… Breast Cancer… University of Nottingham(UK) and Mayo Clinic (USA) Chairman, Foundation for Breast Cancer Care… Background: To compare already used serum markers in advanced breast cancer, namely erythrocyte…
Breast and Endocrine Surgeon, Mater Hospitals South Brisbane.
Previous Fellowships at University of Nottingham(UK) and Mayo Clinic (USA)
Chairman, Foundation for Breast Cancer Care
Senior Surgeon Breast Screen Qld Metro south Brisbane
Breast Cancer Quality Audit - >140,000 entries , identiying gaps in service delivery to Breast Cancer patients
Matched phrases in profile:
The LACE study is a clinical trial comparing two types of surgery for women with early-stage cancer… Cancer specialists are aware that not only the survival time but also the quality of life is a key… The value of serum CA125 for the development of virtual follow-up strategies for patients with epithelial ovarian cancer: A retrospective study… feMMe: Uterus-preserving treatment of endometrial cancer… Prophylactic surgery and breast cancer… levonorgestrel intrauterrine device (LNG-IUD) to treat endometrial cancer. The next two steps… Professor Obermair is the Director of Queensland Centre for Gynaecological Cancer Research (QCGC… Background: Serum CA125 is routinely used in the follow up of ovarian cancer. The objective of the…
Professor Obermair is the Director of Queensland Centre for Gynaecological Cancer Research (QCGC Research). He is a Professor of Gynaecological Oncology since 2007, a Senior Medical Officer at Royal Brisbane & Women’s Hospital and a Visiting Medical Officer at St Andrews War Memorial Hospital and …
Professor Obermair is an innovative and skilled gynaecologic oncologist, surgical teacher and consumer advocate. His international leadership and research impact was acknowledged in 2020 by the Australian community, when he was awarded an NHMRC Investigator Fellowship Level 2 (2021-25). The national …
Matched phrases in profile:
Therapeutic Opportunity in Cancers with Poor Survival… Complex neoantigen prediction in cancers… genome sequencing technologies in biomedical research. In particular large cancer research…
Research officer, Medical Genomics
QIMR Berghofer Medical Research Institute
My research addressed the challenges related to key genomic components in tumour-immune editing variation in cancers with poor survival and predicting the responses to cancer immunotherapies. Characterizing genomic determinants in underlying response and resistance to cancer immunotherapy. Through w …
Matched phrases in profile:
Total Laparoscopic Hysterectomy (TLH) among a total of 760 patients with Endometrial Cancer (EC). LACE… My quality of life research focuses on interventions that can help people with cancer to improve their wellbeing… Quality of life after early enteral feeding versus standard care for proven or suspected advanced epithelial ovarian cancer: Results from a randomised trial… Prevention of cervical cancer… Redesigning skin cancer early detection and care (NHMRC Partnership Project administered by QUT)… Did you know that cervical cancer is one of the most avoidable cancers in the world? Despite… background in cancer prevention and quality of life research, with strong clinical collaborations, and a… Background Malnutrition is common in patients with advanced epithelial ovarian cancer (EOC), and is…
Professor Monika Janda is the Director, Centre for Health Services Research, and Professor in Behavioural Science, at the Faculty of Medicine, University of Queensland, and a recent NHMRC Translational Research Fellow (2018-20). Professor Janda leads the NHMRC Centre for Reserch Excellence in Skin I …
Professor Janda has three main research interests i) prevention and early detection of cancer (in particular melanoma); ii) improving clinical and supportive care for cancer patients (in particular gynaecological cancers), as well as iii) innovative methods of health services delivery and digital in …
Matched phrases in profile:
Using published datasets, and tissue donated by Brisbane breast cancer patients, we're trying to… Post-transcriptional regulation of the breast cancer susceptibility gene BRCA1 by Hu Antigen-R… Development of new theranostic agents for metastatic breast cancer surveillance and treatment… Molecular validation of autofluorescence and narrow band imaging of oral cancer resection margins… Most of the time, treatments for early breast cancer successfully prevent metastatic spread, but… Biomarkers of triple-negative breast cancer progression and response to therapy… cancer. Based at Brisbane’s Translational Research Institute, she was recruited by Mater Research… BRCA1 is a breast cancer susceptibility gene that is down-regulated in the majority of cases of…
Dr Jodi Saunus is a senior fellow who specialises in translational research on metastatic breast cancer. Based at Brisbane’s Translational Research Institute, she was recruited by Mater Research in 2022 to help facilitate patient-focused research at the interface of biomedical R&D and clinical pra …
Matched phrases in profile:
. Survivin and XIAP have emerged as attractive targets for cancer therapeutics. This project will… Vincristine pharmacodynamics and pharmacogenetics in children with cancer: A limited-sampling, population modelling approach… Life and health after childhood cancer: a national data linkage cohort study (Cancer Australia grant led by The University of Sydney)… Blood Cancers… local, national and international collaborative research across all childhood cancer types. A/Prof… attractive small molecule targets for cancer therapeutics, with several inhibitors currently in…
Associate Professor Andy Moore is a Paediatric Oncologist and Director of Research at Children's Health Queensland Hospital & Health Service (CHQ). He is also Director of the Queensland Children's Tumour Bank, which is part of UQ's Child Health Research Centre. The Queensland Children's Tumour Bank …
Matched phrases in profile:
Head and neck cancers (HNC) are the 7th most common cancer and account for 2,500 new cases in… Applications in lung, skin, and head and neck cancers.… Transformation or progression from adenocarcinoma to small cell lung cancer detected by serially tracking mutations in the blood… From Pixels to Prognosis: Harnessing single-cell spatial analysis to predict and improve immunotherapy response in lung cancer… approaches in the Asia-Pacific region, contributing to world-first studies for lung cancer, head… cancers (HNCs). Whilst the prognostic and predictive value of single CTCs have been well documented…
Dr Arutha Kulasinghe is a Senior Research Fellow and leads the Clinical-oMx Lab at the University of Queensland. Dr Kulasinghe has pioneered spatial transcriptomics using digital spatial profiling approaches in the Asia-Pacific region, contributing to world-first studies for lung cancer, head and ne …
Matched phrases in profile:
Cancers in Australia in 2010 attributable to infectious agents… Obesity-induced Barrett's oesophagus and associated cancer: mechanisms and diagnostic tools… Obesity and cancer… Professor Bradley Kendall is a clinical academic Gastroenterologist and Cancer Epidemiologist… average risk for developing EAC; these individuals might benefit from targeted cancer-prevention strategies. …
Professor Bradley Kendall is a clinical academic Gastroenterologist and Cancer Epidemiologist. He is currently a Senior Staff Gastroenterologist (Eminent) at the Princess Alexandra Hospital, Brisbane with over 30 years of experience in clinical practice. His clinical training included Fellowships in …
Professor Kendall’s work on the role of obesity in gastrointestinal cancer has been acknowledged nationally and internationally. His work has a strong translational focus contributing to the development of clinical risk prediction tools, national clinical guidelines, and position statements. As an …
Matched phrases in profile:
modalities of neoadjuvant therapy – results from the AGITG DOCTOR trial and the cancer evolution biobank… Cancer genetics… Barbour. Dr Brosda was awarded a PhD in bioinformatics and cancer genetics from the… set of 89 esophageal cancer samples. The most hypermethylated tumors showed worse patient survival.…
Dr Sandra Brosda is a Research Fellow within the Surgical Oncology group led by Professor Andrew Barbour.
Dr Brosda was awarded a PhD in bioinformatics and cancer genetics from the University of Queensland in November 2020. Her research focused on biomarker discovery and intra-tumour heterogeneity …
Matched phrases in profile:
Cell biology: Ran, mitosis and the cancer Lconnection… Cancer chemotherapy… studying cancer, autoimmune diseases, infection and immunity, and the genetic basis of disease… -9 phosphorylation in the regulation of apoptosis during development and in pathological states, including cancer.…
Paul Clarke is Director of the Frazer Institute, a leading translational medical research centre studying cancer, autoimmune diseases, infection and immunity, and the genetic basis of disease. Professor Clarke became Director in 2017 and was previously Associate Dean (Research) in Medicine at the Un …